TAK-743-4013
Completed
A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada
Clinicaltrials.gov
#NCT05578417About this clinical trial
The main aim of this study is to describe the characteristics of participants, check for number of hereditary angioedema (HAE) cases, their treatment and outcomes. Another aim is to check how the healthcare facilities were utilized for treatment. Participants' data will be taken from their medical records (charts), which were already collected as a part of their routine care between January 1, 2012, and January 1, 2022.
CA
Observational clinical trial.
At a glance
What medical conditions were being studied?
Hereditary Angioedema (HAE)
Angioedema
What was the clinical trial testing?
No Intervention
How many participants were enrolled?
60
Were placebos part of the clinical trial?
No
When was the clinical trial conducted?
Jun 2023 - Jun 2024
How long was participation in the clinical trial?
Not applicable. Data collected between January 1, 2012, and January 1, 2022, will be checked (up to approximately 10 years).
Key requirements
Sexes
All
Age
12+ years
Healthy volunteers?
No
Entry criteria
Data of the following participants will be reviewed:
Boys and girls, and men and women aged 12 years or older.
Diagnosed with HAE with normal C1 inhibitor function (HAE nC1-INH) or non-hereditary angioedema with normal C1 inhibitor function (NHAE nC1-INH; also known as idiopathic angioedema).